viernes, 15 de octubre de 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

No hay comentarios:

Publicar un comentario